These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25960135)

  • 21. Chemical profiles and pharmacological activities of Chang-Kang-Fang, a multi-herb Chinese medicinal formula, for treating irritable bowel syndrome.
    Mao Q; Shi L; Wang ZG; Luo YH; Wang YY; Li X; Lu M; Ju JM; Xu JD; Kong M; Zhou SS; Shen MQ; Li SL
    J Ethnopharmacol; 2017 Apr; 201():123-135. PubMed ID: 28263849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colonic mucosal N-methyl-D-aspartate receptor mediated visceral hypersensitivity in a mouse model of irritable bowel syndrome.
    Qi QQ; Chen FX; Zhao DY; Li LX; Wang P; Li YQ; Zuo XL
    J Dig Dis; 2016 Jul; 17(7):448-57. PubMed ID: 27356126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imbalanced shift of cytokine expression between T helper 1 and T helper 2 (Th1/Th2) in intestinal mucosa of patients with post-infectious irritable bowel syndrome.
    Chen J; Zhang Y; Deng Z
    BMC Gastroenterol; 2012 Jul; 12():91. PubMed ID: 22816602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atractylodes oil alleviates diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and intestinal barrier via SCF/c-kit and MLCK/MLC2 pathways.
    Xie Y; Zhan X; Tu J; Xu K; Sun X; Liu C; Ke C; Cao G; Zhou Z; Liu Y
    J Ethnopharmacol; 2021 May; 272():113925. PubMed ID: 33592255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction.
    Shi HL; Liu CH; Ding LL; Zheng Y; Fei XY; Lu L; Zhou XM; Yuan JY; Xie JQ
    World J Gastroenterol; 2015 Apr; 21(16):4852-63. PubMed ID: 25944998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electroacupuncture Relieves Irritable Bowel Syndrome by Regulating IL-18 and Gut Microbial Dysbiosis in a Trinitrobenzene Sulfonic Acid-Induced Post-Inflammatory Animal Model.
    Song YF; Pei LX; Chen L; Geng H; Yuan MQ; Xu WL; Wu J; Zhou JY; Sun JH
    Am J Chin Med; 2020; 48(1):77-90. PubMed ID: 31918565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.
    Sereti I; Estes JD; Thompson WL; Morcock DR; Fischl MA; Croughs T; Beq S; Lafaye de Micheaux S; Yao MD; Ober A; Wilson EM; Natarajan V; Imamichi H; Boulassel MR; Lederman MM; Routy JP
    PLoS Pathog; 2014 Jan; 10(1):e1003890. PubMed ID: 24497828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulated adenosine 2A receptor accelerates post-infectious irritable bowel syndrome by promoting CD4+ T cells' T helper 17 polarization.
    Dong LW; Ma ZC; Fu J; Huang BL; Liu FJ; Sun D; Lan C
    World J Gastroenterol; 2022 Jul; 28(25):2955-2967. PubMed ID: 35978875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oridonin Alleviates Visceral Hyperalgesia in a Rat Model of Postinflammatory Irritable Bowel Syndrome: Role of Colonic Enterochromaffin Cell and Serotonin Availability.
    Zang KH; Shao YY; Zuo X; Rao Z; Qin HY
    J Med Food; 2016 Jun; 19(6):586-92. PubMed ID: 27111743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Key factors in developing the trinitrobenzene sulfonic acid-induced post-inflammatory irritable bowel syndrome model in rats.
    Qin HY; Xiao HT; Wu JC; Berman BM; Sung JJ; Bian ZX
    World J Gastroenterol; 2012 May; 18(20):2481-92. PubMed ID: 22654445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis.
    Del Valle-Pinero AY; Sherwin LB; Anderson EM; Caudle RM; Henderson WA
    World J Gastroenterol; 2015 Jan; 21(1):155-63. PubMed ID: 25574088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum and colonic mucosal immune markers in irritable bowel syndrome.
    Chang L; Adeyemo M; Karagiannides I; Videlock EJ; Bowe C; Shih W; Presson AP; Yuan PQ; Cortina G; Gong H; Singh S; Licudine A; Mayer M; Tache Y; Pothoulakis C; Mayer EA
    Am J Gastroenterol; 2012 Feb; 107(2):262-72. PubMed ID: 22158028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiinflammatory and immunomodulatory activity of an ethanolic extract from the stem bark of Terminalia catappa L. (Combretaceae): In vitro and in vivo evidences.
    Abiodun OO; Rodríguez-Nogales A; Algieri F; Gomez-Caravaca AM; Segura-Carretero A; Utrilla MP; Rodriguez-Cabezas ME; Galvez J
    J Ethnopharmacol; 2016 Nov; 192():309-319. PubMed ID: 27452660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of intestinal lamina propria dendritic cells in a mouse model of postinfectious irritable bowel syndrome.
    Long Y; Wang W; Wang H; Hao L; Qian W; Hou X
    J Gastroenterol Hepatol; 2012 May; 27(5):935-44. PubMed ID: 22141367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal anti-inflammatory activity of hydroalcoholic extracts of Phlomis purpurea L. and Phlomis lychnitis L. in the trinitrobenzenesulphonic acid model of rat colitis.
    Algieri F; Zorrilla P; Rodriguez-Nogales A; Garrido-Mesa N; Bañuelos O; González-Tejero MR; Casares-Porcel M; Molero-Mesa J; Zarzuelo A; Utrilla MP; Rodriguez-Cabezas ME; Galvez J
    J Ethnopharmacol; 2013 Apr; 146(3):750-9. PubMed ID: 23395625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of moxibustion on colonic low-grade inflammatory response in rats with diarrhea-predominant irritable bowel syndrome based on mast cell degranulation.
    Fang M; Chu H; Song X; Ruan J; Zou L; Li K; Liao L; Ma W; Han X; Zhu J; Wang Z; Fang Y
    Zhongguo Zhen Jiu; 2024 Mar; 44(3):283-294. PubMed ID: 38467503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Da-Jian-Zhong decoction alleviates diarrhea-predominant irritable bowel syndrome via modulation of gut microbiota and Th17/Treg balance.
    Zhang MM; Dang M; Wu X; Ou L; Li M; Zhao CB; Wei PF; Dong TW; Li Y; Wu CJ
    J Ethnopharmacol; 2024 Sep; 331():118275. PubMed ID: 38729534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats.
    Yu ZC; Cen YX; Wu BH; Wei C; Xiong F; Li DF; Liu TT; Luo MH; Guo LL; Li YX; Wang LS; Wang JY; Yao J
    World J Gastroenterol; 2019 Aug; 25(29):3956-3971. PubMed ID: 31413530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection--an observation in a small case control study.
    Kim HS; Lim JH; Park H; Lee SI
    Yonsei Med J; 2010 Jan; 51(1):45-51. PubMed ID: 20046513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.